Claudio Bordignon
In 1992 Doctor Claudio Bordignon working at the
In 2005, he was nominated by the European Commission as one of the 22 founding members of the European Research Council (ERC).[4]
Dr. Bordignon was the first President of the European Working Group on Human Gene Transfer and Therapy (EWGT), now known as the European Society of Gene and Cell Therapy (ESGCT). In 2010, he was awarded the ESGCT Outstanding Achievement Award, along with Alessandro Aiuti and Maria Grazia Roncarlo in recognition of their contributions to the field.[5]
Dr Bordignon graduated in medicine from the University of Milan, where he specialized in Internal Medicine and in Hematology.[6]
References
1) Gene therapy. Italians first to use stem cells. Abbott A. Nature. 9 April 1992;356(6369):465.
2) Patent: 20080286305 Antigen Transduced T Cells Used as a Delivery System for Antigens 11-20-2008
References
- ^ "Bordignon: "La terapia genica ci allungherà la vita (ma non troppo)"". Corriere della Sera (in Italian). 14 September 2018. Retrieved 13 November 2019.
- ^ "Thirteenth World Conference – The Lives to Come – Claudio Bordignon". thefutureofscience.org. Retrieved 13 November 2019.
- ^ "Claudio_Bordignon". researchgate.net.
- ^ "Claudio Bordignon". thepharmaletter.com. Retrieved 13 November 2019.
- ^ "ESGCT Awards".
- ^ "Press corner". European Commission – European Commission. Archived from the original on 13 November 2019. Retrieved 13 November 2019.